Physician-assisted doping of athletes has transformed high-performance sport into a chronically overmedicated subculture and spread so-called hormonal rejuvenation to the general public.
Physicians, scientists, and public health officials are routinely on the defensive, refuting allegations of unconfirmed risks, justifying the value of vaccines, and striving to preserve public trust in vaccination overall.
Marwan Hariz, MD, PhD and Jordan P. Amadio, MD, MBA
Deep brain stimulation (DBS) for enhancements of non-disease states is ethically indefensible given our incomplete knowledge of this technology. Attention should instead be focused on increasing access to DBS for patients with illnesses potentially treatable by the procedure.
This month, AMA Journal of Ethics editor-in-chief Audiey Kao, MD, PhD, interviewed Peter A. Ubel, MD, about factors contributing to the high cost of health care, how to bend the cost curve, and the compatibility of cost containment and profit seeking.
AMA J Ethics. 2015;17(9):826-833. doi:
10.1001/journalofethics.2015.17.9.ecas2-1509.
Karlie A. Intlekofer, PhD, Michael J. Cunningham, MS, and Arthur L. Caplan, PhD
When public figures imperil the safety of the public with inaccurate claims that discourage vaccination, it is imperative that both organized medicine and individual physicians speak up.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
Both public health agencies and vaccine companies have a stake in promulgating good information about vaccines: where the government sees gaps in immunization coverage, vaccine manufacturers see gaps in market coverage. Why shouldn't they work together to close them?
David Elkin, MD, Erick Hung, MD, and Gilbert Villela, MD
The rapidly evolving field of neuroethics is concerned with the ethical questions that new technologies will pose about autonomy, privacy, the definition of normal, and individuality.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.